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INVESTIGATIONS OF INTER- AND INTRA-INDIVIDUAL
RELATIONSHIPS BETWEEN ABSORPTION OF ORAL
SALMON CALCITONIN AND A SURROGATE MARKER OF
PHARMACODYNAMIC EFFICACY
M.A. Karsdal, I. Byrjalsen, K. Henriksen, B.J. Riis,
C. Christiansen
Nordic BioSci. A/S, Herlev, Denmark
Purpose: The aim of the study was to compare inter- and intra-
individual bioavailability of 0.8 mg of oral salmon calcitonin (sCT)
given once before or after food intake to assess the relationship
between bioavailability and levels of the bone resorption biomarker,
serum C-terminal telopeptide of collagen type I (CTX-I).
Methods: Participants were from two randomized, double-blind,
placebo-controlled studies. Study I was a cross-over trial including
healthy postmenopausal women receiving a single dose of 0.8
mg of oral sCT or placebo pre-breakfast at 08:00 (n=42), pre-
dinner at 17:00 (n=20), or post-dinner at 22:00 (n=19). Blood
samples were taken before drug intake, and at 5, 10, 15, 30, 45
minutes, 1, 1½, 2, 2½, 3 hours, and every subsequent hour until
24 hours after dosing. Study II investigated the pharmacokinetics
and pharmacodynamics of oral sCT administered on days 1 and
14 to postmenopausal women and men (n=73) suffering from
osteoarthritis (OA). In one treatment arm, 0.8 mg of oral sCT was
given twice daily with one dose in the morning at 08:00 and one
dose given pre-dinner at 17:00 (n=26). On treatment day 1 and
day 14, blood samples were taken before drug intake, and at 10,
15, 30, 45 minutes, and 1, 2, and 4 hours post-dose. In both
studies the absorption of calcitonin was assessed by plasma sCT
concentrations, and bone resorption by the biochemical marker of
serum CTX-I.
Results: Irrespective of dosing time, a single dose of 0.8 mg
oral sCT was rapidly absorbed, reaching Cmax between 15 to 30
minutes in both low and high absorbers. Following Cmax, sCT
was eliminated from plasma with a half-life between 9 and 15
minutes. Overall, a single dose of 0.8 mg oral sCT resulted in
signiﬁcant suppression of serum CTX-I compared with placebo
irrespective of the level of absorption of sCT. At all three dosing
times a signiﬁcantly higher suppression of sCTX-I was observed in
subjects with the highest intestinal absorption of sCT. The effect of
increased absorption of sCT was a marked prolongation of serum
CTX-1 suppression whereas acute suppression 1 to 2 hours after
dosing was unaffected. A high degree of correlation between the
level of absorption of sCT and the suppression of serum CTX-I
was observed at all three dosing times, i.e. a Pearson correlation
coefﬁcient of r = -0.74, r = -0.94, and r = -0.78, was found at
the dose times 08:00, 17:00, and 22:00. A weak association of
borderline signiﬁcance was found in the intra-individual absorption
of sCT on dosing days 1 and 14 with r = 0.40 and r = 0.38 at
the dose times 08:00 and 17:00. As expected, the intra-individual
response in serum CTX-I levels was statistically non-signiﬁcantly
associated on dosing days 1 and 14 with r = 0.34 and r = 0.27 at
the dose times 08:00 and 17:00.
Conclusions: Increased bioavailability of orally administered 0.8
mg sCT is highly correlated with suppression of the bone resorp-
tion marker, serum CTX-I. Moreover, the effect is highly controlled
with a minimum of individual variability in serum CTX-I. The
variable absorption of the drug demonstrates the importance of
determining the optimal conditions for ensuring a most beneﬁcial
drug uptake.
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Chang Gung Mem. Hosp. -Kaohsiung Med. Ctr., Chang Gung
Univ. Coll. of Med., Taiwan, Kaohsiung Hsien, Taiwan
Purpose: The effect of shockwave in osteonecrosis of the femoral
head (ONFH) is poorly understood. The purpose of this study was
to investigate the regeneration effects of shockwave in ONFH.
Methods: This study consisted of 14 femoral heads from 14 pa-
tients undergoing total hip arthroplasty for ONFH. Seven patients
with seven hips who received shockwave prior to surgery were
designated as the study group, whereas, seven patients with seven
hips who did not receive shockwave were assigned to the control
group. Both groups showed similar demographic characteristics.
The femoral heads were investigated with histopathological ex-
amination and immunohistochemical analysis with von Willebrand
factor (vWF), VEGF, platelet endothelial cell adhesion molecule-1
(PECAM-1) also referred to as (CD 31) and vascular cell adhesion
molecule (VCAM) for angiogenesis, and with proliferation cell nu-
clear antigen (PCNA), Dickkopf-1 (DKK1) and Winless 3a (Wnt 3)
for bone remodelling and regeneration.
Results: In histopathological examination, the study group showed
signiﬁcantly more viable bone and less necrotic bone, higher
cell concentration and more cell activities including phagocy-
tosis than the control group. In immunohistochemical analysis,
the study group showed signiﬁcant increases in vWF (P<0.01),
VEGF (P<0.0012) and CD 31 (P<0.0023), Wnt3 (P<0.008) and
PCNA (P<0.0011), and decreases in VCAM (P<0.0013) and
DKK1 (P<0.0007) than the control group.
Conclusions: Shockwave treatment signiﬁcantly promotes angio-
genesis and bone remodelling than the control. It appears that
application of shockwave results in regeneration effects in hips
with ONFH.
340
CORE TEMPERATURE OF END-STAGE OSTEOARTHRITIC
KNEE
M. Ota1, T. Sasho1, K. Nakagawa1, H. Tsuruoka1, S. Sato1,
S. Maki1, K. Takahashi1, T. Lee2, C. Shirai2
1chiba Univ., Chiba, Japan; 2chiba rehabilitation center, Chiba,
Japan
Purpose: Knee osteoarthritis (KOA) is one of the commonest
joint diseases in an aged society. Among several complaints
patients have, knee pain is most bothering to the patients. But the
mechanisms concerning knee pain are poorly understood. Certain
researchers refer to blood ﬂow disturbance of the subchondral
bone in KOA as possible cause of knee pain. Up until now, several
studies have been performed about blood ﬂow of bone marrow
in femur and tibia, and controversial results have been reported.
In the present study, we measured the core temperature of OA
knees which is considered to reﬂect blood ﬂow of deep structures.
Methods: End-stage KOA patients who were hospitalized and
were waiting for total knee althroplasty (TKA) were involved in this
study (n=16). As a control knees, healthy volunteers who had not
had any knee symptoms were selected (n=10). Measurement of
the core temperature of knee joint as well as sternum area was
performed using Core-temp CM-210 (Terumo, Tokyo). With this
apparatus core temperature was measured by simply attaching
small metal probe to skin surface. (Zero-heat-ﬂow method) Core
temperatures of both groups of knees were monitored over night
on ten-minute basis and compared. Moreover end-stage patients
were divided into two groups: i.e.; those with night pain (N-group)
